BEAM Chemotherapy: Combination Chemotherapy Regimens

BEAM chemotherapy is an acronym representing a small family of combination chemotherapy regimens that are used chiefly as salvage regimens in the context of Hodgkin's lymphoma that includes dexa-BEAM and mini-BEAM. They are also used as salvage or preparative regimens, some prior to stem cell transplantations.

BEAM Chemotherapy Drugs

The drugs that are in the standard BEAM chemotherapy are:

Call

BCNU (carmustine)
Etoposide
Ara-C (cytarabine)
Melphalan

BEAM chemotherapy is an intense, high-dose six-day regimen that normally unrolls like this:

BEAM Chemotherapy Doses

Day 1: Carmustine (intravenous)
Days 2, 3, 4, 5: Etoposide (intravenous infusion); Cytarabine (intravenous infusion)
Day 6: Melphalan (intravenous)
Day 7: The patient undergoes the scheduled autologous stem cell transplantation

[Technically, the days should be numbered as a countdown; i.e. day 1= day -6, day 2=day -5 and so on until day 7, which equals day 0. I have done the opposite for easier understanding].

Dexa-BEAM Chemotherapy

Dexa-BEAM is an intense salvage chemotherapy regimen. The drugs used are as follows:

Dexamethasone
BCNU (carmustine)
Etoposide
Ara-C (cytarabine)
Melphalan

Dexa-BEAM chemotherapy unfolds as follows:

Cycle length: 28 days
Number of cycles: 2-4
Days 1-10: Dexamethasone (oral)
Day 2: BCNU (carmustine)
Day 3: Melphalan
Days 4-7: Etoposide (IV) & cytarabine (IV)

Mini-BEAM Chemotherapy

Mini-BEAM chemotherapy is a less dose-intense regimen that can be used as salvage chemotherapy or as a preparative regimen for a stem cell transplantation.

Cycle length: 28 days
Number of cycles: 2-4
Day 1: Carmustine
Days 2-5: Etoposide (IV); cytarabine (IV)
Day 6: Melphalan (IV)

If this regimen is used as a preparative regimen for a stem cell transplantation, the transplant would occur on the seventh day.

Sources

Boyiadzis, Michael M. et al. Hematology-Oncology Therapy. New York: McGraw Hill, Medical Publishing Division.

Perry, Michael C, Editor. Companion Handbook to the Chemotherapy Sourcebook. Baltimore; Williams & Wilkins.

Photo: Pexels

Call

More Articles

More Articles

This entry looks at Non Hodgkin's Lymphoma in the lungs, clinically known as pulmonary lymphoma, one of the subtypes of lymphoma. 'Lymphoma' is an...

In order to prevent developing any subtype of lymphoma, it would be helpful to know the causes of lymphoma. Unfortunately, in virtually every case...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

The Erythrocyte Sedimentation Rate (ESR - sometimes called sed rate or sedimentation rate) is a nonspecific screening test for various...

Blood counts can be used to identify disease and monitor patient health during cancer treatments. Though these tests cannot diagnose lymphoma on...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...

Secondary cancers are cancers that develop as a result of chemotherapy and/or...